Such patients often carry the type 2 diabetes-associated TCF7L2 gene variant [44] and are more often overweight compared with patients with a more severe autoimmune reaction, i.e. multiple autoantibodies [45]. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.